Bausch + Lomb announced it has received 510(k) clearance from the U.S. FDA for the Stellaris Elite™ phacoemulsification platform, and also recently launched ULTRA® for Astigmatism contact lenses.
The new Stellaris Elite will reportedly be the first phacoemulsification platform on the market to offer Adaptive Fluidics™, which combines precise aspiration control with predictive infusion management to create a highly responsive and controlled surgical environment for efficient lens removal. This system also reportedly aims to reduce intraocular pressure (IOP) fluctuation and post-occlusion surge through variable infusion pressure in response to changes in vacuum levels.
Click here to read the full press release.
And the new ULTRA for Astigmatism contact lenses are a monthly silicone hydrogel lens that combines the company's MoistureSeal® technology that helps maintain 95 percent of lens moisture for a full 16 hours, with OpticAlign™ design, reportedly engineered for stability to promote a successful first fit.
Click here to read the full press release.
Like what you read? Follow OphthalmologyWeb to keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.